Articles related to TYPE 2 DIABETES

“Selecting a GLP-1 receptor agonist over another antihyperglycemic drug could plausibly confer ancillary benefit” in patients at high risk for or living with an SUD. — Study authors

“It gives clinicians objective clinical evidence guidance as to the risks and benefits of napping and catching up on sleep during weekends.” — Kaushik Govindaraju, DO, Medical Offices of Manhattan

“If you exercise and take metformin and your blood glucose does not go down, that’s a problem. People taking metformin also didn’t gain fitness. That means their physical function isn’t getting better, and that could have long-term health risk.” – Steven Malin, Lead Author

“What is the smallest step I can take right now to move forward? I can do this 1 thing, and then build on it. This all began with just one healthy habit, implemented over the course of one week, a single day at a time.”

Across the board, for all outcomes—acute pancreatitis, all-cause mortality, hospitalizations, ICU admissions—we saw significant reductions in patients on GLP-1s compared to chronic pancreatitis patients not on these drugs.” – Mahmoud Y. Madi, MD

People who consumed the highest amount of sweeteners showed faster declines in overall thinking and memory skills than those who consumed the lowest amount, with a decline that was 62% faster. This is the equivalent of about 1.6 years of aging.